|
4 December 2018
VIPRD Digital Biobank VIPRD digital biobank The Virtual Institute of Poverty-Related Diseases (VIPRD) was built under project EURIPRED partially financed by the European Commission. The platform hosts the first in the world comprehensive directory of biobanks that are related to PRD (biobanks that collect: human whole blood, blood products (plasma, serum, RBC, white cells, protein, DNA/RNA from patients with HIV, TB, HEP and Malaria). Currently, the VI biobank also includes in its directory biobanks with tumor and biopsy materials spanning all types of common and rare pathologies and indications, carcinomas and cancers of all types and subtypes, (lung cancer, liver cancer, bladder cancer, bone cancer, brain cancer, breast cancer, colorectal cancer, colon cancer, Hodgkins and non-Hodgkins lymphoma, kidney/renal cancer, leukemia, melanoma, ovarian cancer, pancreatic cancer, prostate cancer, urinary cancer etc). Also available are samples from normal and neurodegenerative CNS indications (Alzheimer’s, Parkinson’s, multiple sclerosis etc.) autoimmune, inflammatory diseases and more. However, the VIPRD’s digital biobank is not only the biobanks directory. The world is producing a large amount of valuable data from its healthcare beneficiaries. It is well-known that this data is hard to reuse due to limitations in the storage capacity. Considering security, scalability, and cross-system interaction, how could researchers take this data and use in their work? The VIPRD team now includes computer scientists, cloud developers and medical professionals who are working on the problem of high quantity and growth of data, rapid scalability, etc. that enabled us to an entirely cloud-based platform for the VIPRD Digital Biobank. This choice of using cloud computing was a new approach for world health providers. Within the EC Project, the team has created the Digital Biobank platform within the Virtual Institute, which would foster research and enable data (for example, genome) storage, automated bioinformatics, and querying and linking across health data types, including genomic, clinical, and other relevant data. The Biobank supports scalable and secure hosting, the management and processing of data, and the analysis of large amounts of health data—including de-identified health records, genomic data, exposure data, electronic health records, etc. By linking data (such as genomics) and clinical information, optimization, cost containment, and security requirements directed the development of the Biobank toward use of the cloud, scalable data storage, full-text search capabilities, and open-source libraries for data visualization the VIPRD Biobank will enable the healthcare provider to more efficiently and effectively provide clinical care and improve health outcomes—supporting targeted health prevention modalities, more efficient research studies, and greater modernization of clinical practice guidelines. |
|
|
3 October 2016
South African AIDS Vaccine Initiative has joined the EURIPRED EXTRANET The South African AIDS Vaccine Initiative (SAAVI) was established in 1999 as an initiative of the South African government and managed as a lead programme of the South African Medical Research Council (SAMRC). SAAVI’s role was to co-ordinate and support the development and testing of HIV vaccines in South Africa with the aim of finding an affordable, effective and locally relevant HIV vaccine. SAAVI was initially funded through grants from the South African Departments of Health and Science & Technology, ESKOM, the Impala Platinum Community Development Trust, Transnet and the European Commission. |
|
|
3 October 2016
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group has joined the EURIPRED EXTRANET "Our mission is to significantly decrease incident HIV and HIV-associated infections and to decrease mortality and morbidity due to HIV and HIV-associated infections and co-morbidities among infants, children, adolescents and pregnant/postpartum women." |
|
|
3 October 2016
International AIDS Vaccine Initiative has joined the EURIPRED EXTRANET The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. Founded in 1996, IAVI works with partners in 25 countries to research, design and develop AIDS vaccine candidates. The organization also conducts policy analysis and serves as an advocate for the AIDS vaccine field. It supports a comprehensive approach to addressing HIV and AIDS that balances the expansion and strengthening of existing HIV prevention and treatment programs with targeted investments in the design and development of new tools to prevent HIV. IAVI is dedicated to ensuring that a future AIDS vaccine will be available and accessible to all who need it. The organization relies on the generous donations of governments, private individuals, corporations and foundations to carry out its mission. |
|
|
3 October 2016
HIV Vaccine Trials Network (HVTN) has joined the EURIPRED EXTRANET The HVTN’s mission is to fully characterize the safety, immunogenicity, and efficacy of HIV vaccine candidates with the goal of developing a safe, effective vaccine as rapidly as possible for prevention of HIV infections globally. |
|
|
3 October 2016
Forum for Collaborative HIV Research has joined the EURIPRED EXTRANET The Forum, founded in 1997, is a public/private partnership addressing cutting edge science and policy issues through a process of stakeholder engagement and deliberation. |
|
|
3 October 2016
Division of AIDS Research (DAR) has joined the EURIPRED EXTRANET The Division of AIDS Research (DAR) supports research to reduce the incidence of HIV/AIDS worldwide and to decrease the burden of living with HIV/AIDS. DAR-supported research encompasses a broad range of studies that includes basic and clinical neuroscience of HIV infection to understand and alleviate the consequences of HIV infection of the central nervous system (CNS), and basic and applied behavioral science to prevent new HIV infections and limit morbidity and mortality among those infected. DAR places a high priority on interdisciplinary research across multiple populations, including racial and ethnic minorities, over the lifespan. |
|
|
3 October 2016
Division of Acquired Immunodeficiency Syndrome (DAIDS) has joined the EURIPRED EXTRANET The Division of AIDS (DAIDS) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Toward that end, the division supports a global research portfolio to advance biological knowledge of HIV/AIDS, its related co-infections, and co-morbidities. With the ultimate goal of creating an “AIDS-Free Generation,” the division develops and supports the infrastructure and biomedical research needed to: 1) halt the spread of HIV through the development of an effective vaccine and biomedical prevention strategies that are safe and desirable; 2) develop novel approaches for the treatment and cure of HIV infection; 3) treat and/or prevent HIV co-infections and co-morbidities of greatest significance; and 4) partner with scientific and community stakeholders to efficiently implement effective interventions. |
|
|
3 October 2016
Centers for AIDS Research (CFAR) has joined the EURIPRED EXTRANET The Centers for AIDS Research (CFAR) program at the National Institutes of Health provides administrative and shared research support to synergistically enhance and coordinate high quality AIDS research projects. CFARs accomplish this through core facilities that provide expertise, resources, and services not otherwise readily obtained through more traditional funding mechanisms. The CFAR program emphasizes the importance of interdisciplinary collaboration, especially between basic and clinical investigators as well as behavioral scientists to support translational research. The CFAR program also encourages training and mentoring of young investigators as well as an inclusion of women and minorities. |
|
|
3 October 2016
Center for HIV/AIDS Vaccine Immunology (CHAVI) has joined the EURIPRED EXTRANET Based on the success of the CHAVI, two new Centers for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) have been established at Duke University and at the Scripps Institute to continue to meet the goal of developing an HIV vaccine. |
News 1 - 10 of 50
First | Prev. | 1 2 3 4 5 | Next | Last
The Virtual Institute- a new online European platform to fight poverty related diseases
The EURIPRED consortium is a partnership of 17 leading organisations in the field of poverty related diseases (PRD) partially supported by the European Commission has developed a new online platform that strenghthens efficient collaboration among researchers working in the field of HIV, TB, Malaria and Hepatitis. The platform has the following modalities:
PRD BioBanks
The virtual BioBank offers the ability to easily share information on available blood samples with the objective to accelerate lifesaving discoveries on PRD. The researcher may directly access the virtual BioBank and enjoy the platform's comprehensive information solutions (such as harmonised search and retrieval of information of large volumes of data) that foster the collaboration and sharing that are essential to advance research.
Online training module
The virtual institute training functionality is a flexible tool that enables the organization and structuring of any eLearning modules. The user can upload his/her content or use existing online content across various platforms (youtube, etc.) to build the online training courses. The monitoring system installed in the training module allows the user to keep records on the most.
Dissemination
The dissemination module may contain documents that are made available to raise awareness among researchers, general public as well as the policy makers, industries and other stakeholders to promote the project vision and its achievements. As a living module, the content may be constantly updated reflecting the impact of the project's dissemination activities addressed to raise awareness and acceptance of scientific and public audiences and reaching the broadest possible audience to create an efficient framework for knowledge transfer between research centers and industries.
The platform has a powerful professional networking module with about 30 different functionalities enabling the user to join or form new networks and significantly strengthen collaboration within the project and with outside world. The project’s partner may invite an external user by forming an extranet network with a limited access to the project's activities for the external users. The virtual institute networking platform enables instant communication within and outside the project. The networking platform has two areas: the first one links the project with external networks and projects and the second is the internal area that reinforces collaboration between the project’s partners via mapped out activities. The internal networking area is a fully protected from the external threats place that enables the users to execute the project’s tasks in much more efficient collaborative way.
Visit the EURIPRED's website
